Menu Back toIQVIA Innovation Theater: Implementing a Rapid Registry (CARE) Solution for Real-World Insights About COVID-19 Symptom Persistence

DIA 2021 Global Annual Meeting

IQVIA Innovation Theater: Implementing a Rapid Registry (CARE) Solution for Real-World Insights About COVID-19 Symptom Persistence

Session Chair(s)

IQVIA

IQVIA

  • IQVIA, United States
As COVID-19 swept across the globe, it heightened the need for relevant data in near real-time. The COVID-19 Active Research Experience (CARE) registry launched in mid-2020, with people reporting from the US and UK about symptom severity and duration, COVID testing, vaccines, risk factors, medications, etc. The CARE infrastructure supports supplementary research like a 28-day symptom study of people who tested positive for COVID-19, a study that was designed and completed in a few months.

Speaker(s)

Matthew Reynolds, PhD, FISPE

Matthew Reynolds, PhD, FISPE

  • Vice President, Real World Evidence
  • IQVIA, United States
Heidi Leister-Tebbe

Heidi Leister-Tebbe

  • Senior Director, Global Product Development
  • Pfizer Inc, United States